Baseline Laboratory Tests for Ulcerative Colitis
For patients with suspected or newly diagnosed ulcerative colitis, obtain a complete blood count (CBC), C-reactive protein (CRP), albumin, and fecal calprotectin as baseline laboratory tests 1.
Essential Baseline Laboratory Panel
The 2025 British Society of Gastroenterology guidelines specify that patients presenting with suspected UC should undergo initial assessment with:
- Complete blood count (CBC) - to assess for anemia (hemoglobin) and thrombocytosis (platelet count)
- C-reactive protein (CRP) - serum inflammatory marker
- Albumin - nutritional status and disease severity marker
- Fecal calprotectin - stool inflammatory biomarker with excellent sensitivity for IBD 1
These tests serve multiple purposes: establishing baseline inflammatory status, assessing disease severity, and excluding infectious causes when combined with stool cultures.
Additional Important Baseline Tests
While the core panel above is essential, comprehensive baseline assessment should include:
- Stool cultures - to exclude Clostridioides difficile and other enteric pathogens, as infections can mimic UC and biomarkers lack specificity for IBD 2, 1
- Erythrocyte sedimentation rate (ESR) - though less specific than CRP, provides additional inflammatory assessment 3, 4
Clinical Context and Performance Characteristics
Important caveats about baseline laboratory interpretation:
Normal labs do not exclude UC: In children with mild UC, 54% had all four baseline tests (hemoglobin, platelets, albumin, ESR) within normal limits 3. Even with moderate-to-severe disease, 26% had normal ESR and 32% had normal hemoglobin 3.
Optimal screening combination: When used for screening suspected IBD, hemoglobin plus platelet count provides 90.8% sensitivity and 80.0% specificity using "1 of 2 abnormal" as the criterion 4. However, if clinical suspicion remains high despite normal results, proceed with endoscopic evaluation.
Disease extent correlation: In UC specifically, there is a direct correlation between disease severity, extent of bowel inflammation, and number of abnormal laboratory tests 3. More extensive colitis produces more laboratory abnormalities.
Biomarker-Specific Thresholds
The 2023 AGA guidelines establish specific thresholds for ongoing management that inform baseline interpretation:
- Fecal calprotectin >150 mg/g indicates active inflammation 2
- Fecal calprotectin <50 mg/g better predicts endoscopic improvement in recently treated patients 2
- CRP elevation has moderate certainty evidence for ruling in active inflammation 2
Critical pitfall: CRP, fecal calprotectin, and fecal lactoferrin can be elevated from non-intestinal sources of infection or inflammation 2. Always correlate with clinical presentation and exclude infections before attributing elevations solely to UC.
Nutritional and Deficiency Screening
For patients with established UC, particularly those with severe disease or prior surgeries, baseline assessment should include:
- Iron studies (iron, ferritin)
- Vitamin B12
- Folic acid
- Zinc levels 5
These help identify deficiencies requiring correction before initiating immunosuppressive therapy.
What NOT to Rely On
Antibody testing (pANCA, ASCA) may help differentiate Crohn's disease from UC 5, but these are not part of routine baseline assessment and should not delay diagnosis or treatment. The diagnosis of UC ultimately rests on endoscopic evaluation and histological assessment, not laboratory tests alone 1.